Regeneron Pharmaceuticals Inc. Watch

from 10-Q 5 pages Certain Information in This Document, Marked by [**], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Amendment No. 3 to the Master Agreement

from 10-Q 4 pages Certain Information in This Document, Marked by [**], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Amendment No. 2 to the Master Agreement

from 10-K 5 pages Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement Pursuant to the Second Amended and Restated Regeneron Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan

from 10-K 5 pages Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Option Agreement Pursuant to the Second Amended and Restated Regeneron Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan

from 10-Q 2 pages Confidential April 14, 2023 Re: Waiver and Consent

from 10-Q 5 pages Certain Information in This Document, Marked by [**], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Amendment No. 1 to the Master Agreement

from 10-Q 13 pages Introduction

from 10-Q 1 page First Amendment to the Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan

from 8-K 38 pages Third Amended and Restated Guaranty Dated as of March 27, 2023 and Effective as of the Restatement Date Made by Regeneron Pharmaceuticals, Inc., as Parent Guarantor, and the Subsidiary Guarantors Party Hereto From Time to Time

from 8-K 77 pages Third Amended and Restated Lease and Remedies Agreement Dated as of March 27, 2023 and Effective as of the Restatement Date Between Old Saw Mill Holdings LLC, as Lessee and Ba Leasing Bsc, LLC, as Lessor Regeneron 2022 Lease Financing This Counterpart Is Not the Original Counterpart

from 8-K 129 pages Third Amended and Restated Participation Agreement Dated as of March 27, 2023 and Effective as of the Restatement Date Among Old Saw Mill Holdings LLC, as Lessee, Ba Leasing Bsc, LLC, as Lessor, Bank of America, N.A., Not in Its Individual Capacity, Except as Expressly Stated Herein, but Solely as Administrative Agent, the Persons Named on Schedule II Hereto, as Rent Assignees Banc of America Leasing & Capital, LLC, as Sole Lead Arranger Jpmorgan Chase Bank, N.A., as Bookrunner Mufg Bank, Ltd., as Bookrunner U.S. Bank National Association, as Bookrunner

from 10-Q 3 pages Certain Confidential Portions of This Exhibit, Marked by Brackets, Were Omitted Because Those Portions Are Not Material and Would Be Competitively Harmful to the Company if Publicly Disclosed

from 10-Q 4 pages Amendment of Solicitation/Modification of Contract 1. Contract Id Code Firm Fixed Price Page 1 of 4 2. Amendment/Modification No. P00003 3. Effective Date 2021jul08 4. Requisition/Purchase Req No. See Schedule 5. Project No. (If Applicable) 6. Issued by Code W15qkn 7. Administered by (If Other Than Item 6) Code W58p05 Army Contracting Command - Nj Picatinny Arsenal, Nj 07806-5000 Email: Rdecom Acquisition Center / Ncd Amsrd-Acc-Nm 10 General Green Ave, Bldg 1 Natick, Ma 01760-5011 8. Name and Address of Contractor (No., Street, City, County, State and Zip Code) Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Rd Tarrytown, Ny 10591-6717 ☐ 9a. Amendment of Solicitation No. 9b. Dated (See Item 11) ☒ 10a. Modification of Contract/Order No. W15qkn-21-C-0014 10b. Dated (See Item 13) 2021jan12 Code 544p9 Facility Code 11. This Item Only Applies to Amendments of Solicitations ☐ the Above Numbered Solicitation Is Amended as Set Forth in Item 14. the Hour and Date Specified for Receipt of Offers ☐ Is Extended, ☐ Is Not Extended. Offers Must Acknowledge Receipt of This Amendment Prior to the Hour and Date Specified in the Solicitation or as Amended by One of the Following Methods

from 10-Q 10 pages Certain Confidential Portions of This Exhibit, Marked by Brackets, Were Omitted Because Those Portions Are Not Material and Would Be Competitively Harmful to the Company if Publicly Disclosed

from 10-Q 7 pages Certain Confidential Portions of This Exhibit, Marked by Brackets, Were Omitted Because Those Portions Are Not Material and Would Be Competitively Harmful to the Company if Publicly Disclosed

from 10-Q 27 pages Certain Confidential Portions of This Exhibit, Marked by Brackets, Were Omitted Because Those Portions Are Not Material and Would Be Competitively Harmful to the Company if Publicly Disclosed

from 10-Q 2 pages Description of Modification

from 10-Q 27 pages Description of Modification

from 10-Q 4 pages Description of Modification

from 10-Q 4 pages Certain Confidential Portions of This Exhibit, Marked by Brackets, Were Omitted Because Those Portions Are Not Material and Would Be Competitively Harmful to the Company if Publicly Disclosed. Fifth Amendment to Amended and Restated License and Collaboration Agreement